Glycemic control in type 2 diabetic patients in public and private Healthcare service;Controle glicêmico de pacientes diabéticos tipo 2 nos serviços público e privado de Saúde

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 6, 2009, Pages 733-740

  Panarotto, Daniel ^a   Träsel, Henrique de Araújo Vianna ^a   de Oliveira, Michele Salibe ^a   Gravina, Lívia Brancher ^a   Teles, Alisson Roberto ^a  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Diabetes mellitus; Hemoglobin glycosylated; Single Health System; Supplemental health; Type 2

Indexed keywords

EID: 70350714328     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000600007     Document Type: Article

References (28)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31.
2. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care. 1992;15(11):1509-16.
3. Brasil. Ministério da Saúde. Secretaria de Atenção Básica. Departamento de Atenção Básica. Diabetes Mellitus. Cadernos de Atenção Básica. Brasília; 2006.
4. Jönsson B, CODE-2 Advisory Board. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45:S5-12.
5. [No authors listed]. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-86.
6. [No authors listed]. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). United Kingdom Prospective Diabetes Study Group (UKPDS). Lancet. 1998;352(9131):837-53.
7. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patientes with type 2 diabetes. N Engl J Med. 2003;348(5):383-93.
8. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl 2):B21-9.
9. Lopez Stewart G, Tambascia M, Rosas Guzmán J, Etchegoyen F, Ortega Carrión J, Artemenko S. Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America. Rev Panam Salud Publica. 2007;22(1):12-20.
10. [No authors listed]. American Diabetes Association. Clinical Practice Recommendations 2001. Diabetes Care. 2001;24(Suppl 1):S1-133.
11. Panarotto D, Teles AR, Schumacher MV. Fatores associados ao controle glicêmico em pacientes com diabetes tipo 2. Rev Assoc Med Bras. 2008;54(4):314-21.
12. American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009;32 Suppl 1:S13-61.
13. Panarotto D, Toss AMM, Teles AR. Levantamento dos métodos de análise de hemoglobina glicada utilizados em laboratórios da Serra Gaúcha. Scientia Med. 2005;15(3):137-41.
14. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88-136.
15. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006;23(6):579-93.
16. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;Suppl 1:1-68.
17. McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002;25(4):718-23.
18. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335-42.
19. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-91.
20. Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ. 2000;321(7258):405-12.
21. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72.
22. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-39.
23. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59.
24. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
25. Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008;31(1):173-5.
26. Nathan D, Buse J, Davidson M, Heine R, Holman R, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006;29(8):1963-72.
27. Huppertz E, Pieper L, Klotsche J, Stridde E, Pittrow D, Böhler S, et al. Diabetes mellitus in German primary care: quality of glycaemic control and subpopulations not well controlled Results of the DETECT Study. Exp Clin Endocrinol Diabetes. 2009;117(1):6-14. Epub 2008 May 9.
28. Yurgin N, Secnik K, Lage M. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin Ther. 2007;29(2):316-25.